Anti-idiotype immunization of cancer patients: modulation of the immune response
about
Antibodies: At The Nexus of Antigens and Cancer VaccinesAdvances in cancer vaccine development.Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1AHuman anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patientsMonoclonal antibodies in the treatment of malignancy: basic concepts and recent developments.Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581Possibilities for active immunotherapy of human cancer.Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccineActive specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.Immunoscreening protocols for the identification of clinically useful antibodies and antigens.Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.Expression of an antigen homologous to the human CO17-1A/GA733 colon cancer antigen in animal tissues.Idiotypic cascades associated with the CD4-HIV gp120 interaction: principles for idiotype-based vaccines.Epitope- and antigen-specific cancer vaccines.Anti-idiotype monoclonal antibodies as vaccines for human cancer.Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotype antibodies mimic an epitope on the tumor antigenMonoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors.The role of the A48 regulatory idiotype in inducing tumor-specific immunity.Modulation of cancer patients' immune responses by anti-idiotypic antibodies.Biologic response modifiers in the treatment of gastrointestinal malignancies.Animal models of human-derived cancer vaccines.Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.Preparation and characterization of anti-anti-idiotypic monoclonal antibody ("Ab1-like Ab3") in relation to carcinoembryonic antigen.Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.Review: analogies between trophoblastic and malignant cells.Colorectal cancer vaccines.Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice.Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma.
P2860
Q27001058-61DCAFD7-2F71-43EB-9B81-BC4729BEFE98Q33603404-123AD357-8CC9-4F3D-B87E-791A5FC8B0E7Q33858524-3EBA5717-2201-4554-9C3C-5E991B62C5C6Q34262315-017812DE-E3A3-47C3-9582-20E3309A69B8Q34478304-1C6B4DF8-4DA0-400E-AD9D-11B5BECDF7ABQ34979517-C09A5605-DC72-46F9-8CB8-6ED0D3025489Q35170266-9DB6A136-5F65-473E-BA2B-91CE69F01FE3Q35326752-75255573-BF6E-48E2-A77B-A62E43695D6FQ35750646-7B5978AE-C986-4469-9624-3BAE07FD7545Q35818561-E112B4FD-7AC4-4C80-A1A7-C6FA800B4D23Q36181177-C6225AAC-BD3C-4649-B5A5-C57A71495595Q36389569-E8E08B07-7696-43B7-90A5-5D8674DAEBD6Q36431169-2A53F93E-17C3-4A57-9CB9-B167CC9B3D9DQ36708986-BABD878F-A52E-4A32-8767-13EF54BBB1DAQ36930069-22420A6E-C5D3-4EEC-818E-8B7A911F61B4Q36930073-A6D66925-364C-4136-977D-8E8B5044F555Q37486766-58B10E2B-7C58-4F78-B285-7A380073D6D5Q37887819-3BE12A1E-48E3-4306-A183-AA7A41E4DF4AQ38213740-E8C97CEF-8420-4661-B4CD-B24C47D6E090Q38246922-68F2346E-E671-415D-B6DA-F3C136D9D06DQ38646374-E3E6F262-F3F5-42F1-BCEB-F961C7755C69Q40378570-2F9DFF8B-AAF9-4545-B1CA-5BA3BD0C186AQ40517098-0B29D8EF-210F-4C55-9217-85BA7592169CQ40691135-94031024-0B2F-43ED-82B9-A2261D2C5005Q40844483-160BA04E-A7BF-47B1-A196-6A22DB7AFEDEQ41698429-3CC16C36-2275-4074-B1C4-C18EF2EBDC65Q41720736-D3FE2FE7-90D2-4580-AEF4-30D95C3589D1Q42816298-F3AC6065-F578-4974-9745-E818D52674E9Q44462328-9C068C4A-BD8E-4AE5-8952-7EB74584A47D
P2860
Anti-idiotype immunization of cancer patients: modulation of the immune response
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
name
Anti-idiotype immunization of cancer patients: modulation of the immune response
@ast
Anti-idiotype immunization of cancer patients: modulation of the immune response
@en
Anti-idiotype immunization of cancer patients: modulation of the immune response
@nl
type
label
Anti-idiotype immunization of cancer patients: modulation of the immune response
@ast
Anti-idiotype immunization of cancer patients: modulation of the immune response
@en
Anti-idiotype immunization of cancer patients: modulation of the immune response
@nl
prefLabel
Anti-idiotype immunization of cancer patients: modulation of the immune response
@ast
Anti-idiotype immunization of cancer patients: modulation of the immune response
@en
Anti-idiotype immunization of cancer patients: modulation of the immune response
@nl
P2093
P2860
P356
P1476
Anti-idiotype immunization of cancer patients: modulation of the immune response
@en
P2093
D Iliopoulos
M Wettendorff
U Dreikhausen
P2860
P304
P356
10.1073/PNAS.84.22.8055
P407
P577
1987-11-01T00:00:00Z